Washington, D.C. — Thousands of bottles of a commonly prescribed blood pressure medication are being recalled across the United States after a manufacturing issue raised concerns about the drug’s effectiveness.
According to an alert issued by the U.S. Food and Drug Administration (FDA), Inventia Healthcare Limited voluntarily recalled certain lots of Chlorthalidone Tablets USP, 25 mg, after testing revealed the medication did not meet required dissolution standards.
The recall affects products distributed nationwide and could impact patients who rely on the medication to help manage high blood pressure and other cardiovascular conditions.
Why the Medication Was Recalled
The FDA said the affected tablets failed dissolution specifications during quality testing.
In simple terms, dissolution testing evaluates how effectively a medication breaks down and dissolves inside the body after it is taken.
When a tablet fails these standards, there is concern that the medication may not release its active ingredient as intended, potentially affecting how well it works.
Although the recall notice did not specify any reported injuries or adverse events linked to the product, the issue prompted the manufacturer to remove the affected lots from distribution.
Because Chlorthalidone is commonly used to help control blood pressure, patients depend on the medication delivering the proper dose in a predictable manner.
More Than 11,000 Bottles Affected
According to the FDA, approximately 11,460 bottles are included in the recall.
The recalled products were distributed by Risiong Pharma Holdings, Inc., which is based in New Jersey.
The recall includes both:
- 100-count bottles
- 1,000-count bottles
Patients and pharmacies are encouraged to review their medication packaging carefully to determine whether they have one of the affected lots.
Lot Numbers Included in the Recall
The FDA alert identifies the following recalled products:
Chlorthalidone Tablets USP, 25 mg
100-count bottles
- Batch Number: RISA24001
- Expiration Date: April 2027
1,000-count bottles
- Batch Number: RISB24002
- Expiration Date: April 2027
Anyone who has medication matching these lot numbers should take note of the recall information and contact a healthcare provider or pharmacist if they have questions.
What Patients Should Do
Health experts generally advise patients not to stop taking prescribed medications without first consulting a healthcare professional.
Suddenly discontinuing blood pressure medication can create additional health risks for some individuals.
Patients who believe they may have the recalled product should check the bottle label, confirm the lot number, and speak with their pharmacist or prescribing physician about replacement options or next steps.
Healthcare providers can help determine whether an alternative supply is needed and ensure treatment continues without interruption.
FDA Continues Monitoring Medication Safety
The recall serves as another reminder of the ongoing quality control measures used throughout the pharmaceutical industry.
Manufacturers are required to meet strict standards designed to ensure medications perform as intended and remain safe for consumers.
When products fail those standards, recalls are often initiated to prevent potential treatment issues and maintain public confidence in prescription medications.
For now, consumers using Chlorthalidone should verify whether their medication is included in the recall and seek guidance from healthcare professionals if necessary.
Have you ever been affected by a medication recall?
What steps do you think manufacturers should take to improve quality control and patient safety? Share your thoughts respectfully in the comments below.